Companies: 10,795·Total market cap: $144.5T
TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation

TLOGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$979
P/E Ratio—
52W High$0.001
52W Low$0.00004
Overview

TetraLogic Pharmaceuticals Corporation (TLOG) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001361248 · TLOG · OTC · as of Jun 9, 2026

Filing snapshot

231
Total Filings
SC 13G/A
Latest Form
2021-02-16
Most Recent
2013
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001361248 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2016-03-16
Fiscal Year End
Mar 16, 2016
Accession No.
0001558370-16-004186
Primary Document
tlog-20151231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001361248 · Accession 0001558370-16-004186

Latest Key Filings

10-QQuarterly Report
10-Q
2016-11-03
View 10-Q on SEC
8-KCurrent Report
8-K
2016-11-22Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 6
2021-02-16
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 5
2019-02-15
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2018-06-27
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 4
2017-09-19
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 3
2017-09-18
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 2
2017-08-30
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 1
2017-08-17
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2017-08-04
View
15-12B15-12B
15-12B
2016-12-02
View
DEF 14AProxy Statement
DEF 14A
2016-12-01
View
PREM14APREM14A
PREM14A
2016-11-22
View
8-KCurrent Report
8-K
2016-11-22
View
3Initial Statement of Beneficial Ownership
3
2016-11-14
View
3Initial Statement of Beneficial Ownership
3
2016-11-14
View
3Initial Statement of Beneficial Ownership
3
2016-11-14
View
Showing 1–15 of 172 filingsForm 4 / 144 hidden· 231 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001361248  |  Exchange: OTC · Healthcare

TetraLogic Pharmaceuticals Corporation (OTC: TLOG) has submitted 231 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001361248, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is TetraLogic Pharmaceuticals Corporation's most comprehensive regulatory disclosure. The most recent TetraLogic Pharmaceuticals Corporation 10-K was filed on 2016-03-16 for fiscal year ending 2016. Historical TLOG 10-K annual reports are available from 2006 through 2016.

Investors researching TetraLogic Pharmaceuticals Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ONPH SEC Filings →AMPE SEC Filings →ARNI SEC Filings →BTTX SEC Filings →PANC SEC Filings →IVBT SEC Filings →BXRXQ SEC Filings →KLDO SEC Filings →
→ TLOG Financials→ TLOG Earnings→ TLOG Insider Trades

Frequently Asked Questions

TLOG SEC Filings · 8 questions

TetraLogic Pharmaceuticals Corporation (TLOG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 231 filings and access original documents at no cost. TetraLogic Pharmaceuticals Corporation's CIK is 0001361248.

TLOG SEC filingsTetraLogic Pharmaceuticals Corporation SEC documentsfind TLOG 10-K